相关实验视频

Updated: Jan 10, 2026

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

早期深度大脑刺激减轻了神经毒素诱导的帕金森病小鼠模型中的帕金森症进展

Miguel Cesar Merino-Ruiz¹, Jair Trapé Goulart², Gabriely Dos Santos Penha²

¹Neuropharma Lab, Department of Physiological Sciences, Institute of Biological Sciences, Campus Universitário Darcy Ribeiro, University of Brasília, 70910-900 Brasília, Distrito Federal, Brazil; Sarah Network of Rehabilitation Hospitals, SMHS 501 Bloco A, 70335-901 Brasília, Distrito Federal, Brazil.

Experimental neurology

|November 24, 2025

概括

在诱导帕金森病 (PD) 症状后24小时启动的深度大脑刺激 (DBS) 在小鼠中减少了运动缺陷并保护了多巴胺神经元. 早期的DBS可能会减缓PD的进展,并提供神经保护,特别是在早期诊断场景中.

科学领域:

神经科学是一个神经科学.
神经学神经学
帕金森病研究研究

背景情况:

深度大脑刺激 (DBS) 是帕金森病 (PD) 的关键症状治疗方法.
动物模型表明DBS可能具有超出症状管理的神经保护性质.
在前运动性帕金森病中早期DBS干预的潜力值得研究.

研究的目的:

为了评估DBS的运动效应和神经保护潜力,在小鼠模型中在诱导多巴胺基性神经退行后24小时启动DBS.
评估早期的DBS是否可以减轻帕金森病的疾病进展.

主要方法:

患有6-二多巴胺 (6-OHDA) 诱导的帕金森症的小鼠在4天内接受了亚thalamic核 (STN) DBS.
用气和旋测试来评估运动功能.
氨酸氧酶 (TH) 免疫组织化学量化多巴胺基神经元存活率和条状内置.

主要成果:

与对照组相比,用DBS治疗的小鼠的体重减轻明显较小.
DBS组表现出肢体使用和Rotarod表现的改善.
尸体解剖分析显示,DBS治疗组中,内神经元和条状神经TH+密度显著增加.

结论:

即使在最初的多巴胺作用损伤后,使用DBS的早期干预也可以改善帕金森病模型中的运动功能.
DBS显示了潜在的神经保护作用,保护多巴胺基神经元及其投射.
这些发现表明,早期DBS的治疗窗口有可能减缓帕金森病的进展.

关键词:

6-OHDA 是一个6 -OHDA的元素.深度大脑刺激是什么?神经保护是一种神经保护.帕金森病的疾病.动物动物

更多相关视频

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Published on: January 15, 2010

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...